RENE VALLES: Open Payments
NPI 1013015189 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 12 payments from 6 companies in 2025. Trend: 2023 $2,386 · 2024 $1,166 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 3 | $352 |
| Janssen Pharmaceuticals, Inc | 2 | $143 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Supernus Pharmaceuticals, Inc. | 3 | $47 |
| Corium, LLC | 2 | $39 |
| Neuronetics, Inc. | 1 | $29 |
Products named: INVEGA SUSTENNA, ABILIFY ASIMTUFII, Dyanavel XR, Onyda XR, Qelbree, Azstarys, NEUROSTAR TMS THERAPY SYSTEM.
Industry payments across UT — which companies pay providers there.
